Aspectos Clínicos y Epidemiológicos del VIH y Condiciones Asociadas

Guzman-Fulgencio, M; Jimenez, JL; Berenguer, J; Fernandez-Rodriguez, A; Lopez, JC; Cosin, J; Miralles, P; Micheloud, D; Munoz-Fernandez, MA; Resino, S.

Plasma IL-6 and IL-9 predict the failure of interferon-alpha plus ribavirin therapy in HIV/HCV-coinfected patients

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2012; 67(5): 1238-1245 Nº de citas: 33 [doi:10.1093/jac/dkr595]

Monge, S; del Romero, J; Rodriguez, C; de Mendoza, C; de Gorgolas, M; Cosin, J; Dronda, F; Perez-Cecilia, E; Pena, JM; Santos, I; Rubio, R; del Amo, J.

Socio-demographic factors associated with the progression of HIV infection and the impact of HAART in a seroconverter cohort in Madrid (1986-2009)

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2012; 30(3): 117-123 Nº de citas: 3 [doi:10.1016/j.eimc.2011.07.016]

Yebra, G; de Mulder, M; Martin, L; Rodriguez, C; Labarga, P; Viciana, I; Berenguer, J; Aleman, MR; Pineda, JA; Garcia, F; Holguin, A.

Most HIV Type 1 Non-B Infections in the Spanish Cohort of Antiretroviral Treatment-Naive HIV-Infected Patients (CoRIS) Are Due to Recombinant Viruses

JOURNAL OF CLINICAL MICROBIOLOGY. 2012; 50(2): 407-413 Nº de citas: 36 [doi:10.1128/JCM.05798-11]

Sobrino-Vegas, P; Rodriguez-Urrego, J; Berenguer, J; Caro-Murillo, AM; Blanco, JR; Viciana, P; Moreno, S; Bernardino, I; del Amo, J.

Educational gradient in HIV diagnosis delay, mortality, antiretroviral treatment initiation and response in a country with universal health care

ANTIVIRAL THERAPY. 2012; 17(1): 1-8 Nº de citas: 47 [doi:10.3851/IMP1939]

Berenguer, J; Fernandez-Rodriguez, A; Jimenez-Sousa, MA; Cosin, J; Zarate, P; Micheloud, D; Lopez, JC; Miralles, P; Catalan, P; Resino, S.

High plasma CXCL10 levels are associated with HCV-genotype 1, and higher insulin resistance, fibrosis, and HIV viral load in HIV/HCV coinfected patients

CYTOKINE. 2012; 57(1): 25-29 Nº de citas: 23 [doi:10.1016/j.cyto.2011.10.020]

Micheloud, D; Berenguer, J; Guzman-Fulgencio, M; Campos, Y; Garcia-Alvarez, M; Catalan, P; Cosin, J; Miralles, P; Lopez, JC; Resino, S.

European Mitochondrial DNA Haplogroups and Metabolic Disorders in HIV/HCV-Coinfected Patients on Highly Active Antiretroviral Therapy

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES. 2011; 58(4): 371-378 Nº de citas: 24 [doi:10.1097/QAI.0b013e31822d2629]

Blasco, AJ; Arribas, JR; Clotet, B; Domingo, P; Gonzalez-Garcia, J; Lopez-Bernaldo, JC; Llibre, JM; Lozano, F; Podzamczer, D; Santamaria, JM; Tuset, M; Zamora, L; Lazaro, P; Gatell, JM.

Costs and cost effectiveness analysis of preferred GESIDA regimens for initial antiretroviral therapy

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2011; 29(10): 721-730 Nº de citas: 11 [doi:10.1016/j.eimc.2011.08.003]

Berenguer, J; von Wichmann, MA; Quereda, C; Miralles, P; Mallolas, J; Lopez-Aldeguer, J; Alvarez-Pellicer, J; De Miguel, J; Crespo, M; Guardiola, JM; Tellez, MJ; Galindo, MJ; Arponen, S; Barquilla, E; Bellon, JM; Gonzalez-Garcia, J.

Effect of accompanying antiretroviral drugs on virological response to pegylated interferon and ribavirin in patients co-infected with HIV and hepatitis C virus

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2011; 66(12): 2843-2849 Nº de citas: 13 [doi:10.1093/jac/dkr362]

Gomez, CE; Najera, JL; Perdiguero, B; Garcia-Arriaza, J; Sorzano, COS; Jimenez, V; Gonzalez-Sanz, R; Jimenez, JL; Munoz-Fernandez, MA; de Quiros, JCLB; Guardo, AC; Garcia, F; Gatell, JM; Plana, M; Esteban, M.

The HIV/AIDS Vaccine Candidate MVA-B Administered as a Single Immunogen in Humans Triggers Robust, Polyfunctional, and Selective Effector Memory T Cell Responses to HIV-1 Antigens

Journal of Virology. 2011; 85(21): 11468-11478 Nº de citas: 70 [doi:10.1128/JVI.05165-11]

Resino, S; Asensio, C; Bellon, JM; Carmona, R; Miralles, P; Lopez, JC; Cosin, J; Alvarez, E; Berenguer, J.

Diagnostic accuracy of the APRI, FIB-4, and the Forns index for predicting liver fibrosis in HIV/HCV-coinfected patients: A validation study

JOURNAL OF INFECTION. 2011; 63(5): 402-405 Nº de citas: 18 [doi:10.1016/j.jinf.2011.07.017]

Sobrino-Vegas, P; Gutierrez, F; Berenguer, J; Labarga, P; Garcia, F; Alejos-Ferreras, B; Munoz, MA; Moreno, S; del Amo, J.

The cohort of the spanish hiv research network (coris) and its associated biobank; organizational issues, main findings and losses to follow-up

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2011; 29(9): 645-653 Nº de citas: 144 [doi:10.1016/j.eimc.2011.06.002]

Mugavero, MJ; May, M; Ribaudo, HJ; Gulick, RM; Riddler, SA; Haubrich, R; Napravnik, S; Abgrall, S; Phillips, A; Harris, R; Gill, MJ; de Wolf, F; Hogg, R; Gunthard, HF; Chene, G; Monforte, AD; Guest, JL; Smith, C; Murillas, J; Berenguer, J; Wyen, C; Domingo, P; Kitahata, MM; Sterne, JAC; Saag, MS.

Comparative Effectiveness of Initial Antiretroviral Therapy Regimens: ACTG 5095 and 5142 Clinical Trials Relative to ART-CC Cohort Study

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES. 2011; 58(3): 253-260 Nº de citas: 21 [doi:10.1097/QAI.0b013e318230372e]

Garcia, F; de Quiros, JCLB; Gomez, CE; Perdiguero, B; Najera, JL; Jimenez, V; Garcia-Arriaza, J; Guardo, AC; Perez, I; Diaz-Brito, V; Conde, MS; Gonzalez, N; Alvarez, A; Alcami, J; Jimenez, JL; Pich, J; Arnaiz, JA; Maleno, MJ; Leon, A; Munoz-Fernandez, MA; Liljestrom, P; Weber, J; Pantaleo, G; Gatell, JM; Plana, M; Esteban, M.

Safety and immunogenicity of a modified pox vector-based HIV/AIDS vaccine candidate expressing Env, Gag, Pot and Nef proteins of HIV-1 subtype B (MVA-B) in healthy HIV-1-uninfected volunteers: A phase I clinical trial (RISVAC02)

VACCINE. 2011; 29(46): 8309-8316 Nº de citas: 85 [doi:10.1016/j.vaccine.2011.08.098]

Guzman-Fulgencio, M; Berenguer, J; Garcia-Alvarez, M; Micheloud, D; Lopez, JC; Cosin, J; de Castro, IF; Catalan, P; Miralles, P; Resino, S.

Soluble Fas and Fas ligand in HIV/HCV coinfected patients and impact of HCV therapy

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES. 2011; 30(10): 1213-1221 Nº de citas: 4 [doi:10.1007/s10096-011-1215-0]

Tejerina, F; de Quiros, JCLB.

Protease Inhibitors as Preferred Initial Regimen for Antiretroviral-Naive HIV Patients

AIDS REVIEWS. 2011; 13(4): 227-233 Nº de citas: 10

Sanchez-Conde, M; Miralles, P; Bellon, JM; Rincon, D; Ramirez, M; Gutierrez, I; Ripoll, C; Lopez, JC; Cosin, J; Clemente, G; Lo Iacono, O; Banares, R; Berenguer, J.

Use of transient elastography (FibroScan (R)) for the noninvasive assessment of portal hypertension in HIV/HCV-coinfected patients

JOURNAL OF VIRAL HEPATITIS. 2011; 18(10): 685-691 Nº de citas: 53 [doi:10.1111/j.1365-2893.2010.01371.x]

Garcia-Alvarez, M; Guzman-Fulgencio, M; Berenguer, J; Micheloud, D; Campos, Y; Lopez, JC; Cosin, J; Miralles, P; Alvarez, E; Resino, S.

European mitochondrial DNA haplogroups and liver fibrosis in HIV and hepatitis C virus coinfected patients

AIDS. 2011; 25(13): 1619-1626 Nº de citas: 14 [doi:10.1097/QAD.0b013e328349820f]

Sanchez-Conde, M; Ramirez, MLM; Cano, JMB; Caminoa, A; Rodriguez, FA; Garcia, JG; Martin, PM; de la Serna, IB; de Quiros, JCLB; Lopez, JRA; Ochaita, JC; Pareja, JFP; Alvarez, E; Berenguer, JB.

Impact of liver steatosis on the correlation between liver stiffness and fibrosis measured by transient elastography in patients coinfected with human immunodeficiency virus and hepatitis C virus

JOURNAL OF VIRAL HEPATITIS. 2011; 18(7): 278-283 Nº de citas: 32 [doi:10.1111/j.1365-2893.2010.01407.x]